CXCR6-B7-H3-CAR-T Cell (St. Jude Children's Research Hospital)

N/A

Report date: 2026/05/14 20:00:28

Base Information

Drug NameCXCR6-B7-H3-CAR-T Cell (St. Jude Children's Research Hospital)

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy

Mechanisms of ActionAnti-CD276C-X-C chemokine receptor type 6 stimulants

TargetsCD276 antigenC-X-C chemokine receptor type 6

Therapy Area/IndicationsOsteosarcoma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesSt. Jude Children'S Research Hospital

China Registration ClassN/A

Develop Information

Active CompaniesSt. Jude Children'S Research Hospital

Inactive CompaniesN/A

Active IndicationsOsteosarcoma

Inactive IndicationsN/A

Other Information

ATC CodeN/A